Neoclouds have emerged as the fastest-growing niche within the data center landscape, with the sector’s revenues nearly doubling on an annual basis. But these AI cloud specialists also carry ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nucana ( (NCNA)) just unveiled an ...
Abstract: Aiming at the important problem of highway traffic flow analysis, this paper proposes a solution based on electronic toll collection (ETC) transaction data. Firstly, the data-driven elements ...
Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials ...
This is the Spring Cloud Data Flow Dashboard user interface (UI). The UI uses Angular. Source code documentation is available at https://cloud.spring.io/spring-cloud ...
Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024 SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards Osavampator (NBI-1065845) is an ...
LONDON and GAITHERSBURG, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering ...
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments ...
Discovered using Lexicon’s unique approach to gene science, pilavapadin (LX9211) is a potent, once-daily, orally delivered, selective, investigational small molecule inhibitor of AAK1, a novel target ...
"We're pleased to share longer-term follow-up data from the REZILIENT1 study of zipalertinib for patients with NSCLC harboring EGFR ex20ins mutations who have been previously treated with amivantamab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results